Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 28.17M | 37.16M | 24.34M | 14.23M | 0.00 |
Gross Profit | 9.11M | 12.92M | 7.21M | 3.94M | -152.37K |
EBITDA | -23.73M | -22.12M | -22.55M | -13.80M | -3.19M |
Net Income | -22.09M | -28.75M | -26.47M | -15.98M | -4.41M |
Balance Sheet | |||||
Total Assets | 12.88M | 31.68M | 49.95M | 44.20M | 6.53M |
Cash, Cash Equivalents and Short-Term Investments | 764.00K | 1.15M | 13.76M | 19.18M | 1.75M |
Total Debt | 1.04M | 4.20M | 6.08M | 2.09M | 9.34M |
Total Liabilities | 40.59M | 45.12M | 43.82M | 14.49M | 10.03M |
Stockholders Equity | -27.71M | -13.44M | 6.13M | 29.71M | -3.50M |
Cash Flow | |||||
Free Cash Flow | -15.16M | -15.75M | -36.20M | -12.54M | -2.55M |
Operating Cash Flow | -15.16M | -15.75M | -35.24M | -10.79M | -1.95M |
Investing Cash Flow | 227.00K | 1.03M | 32.42M | 9.64M | -554.07K |
Financing Cash Flow | 10.67M | 5.10M | 196.00 | 25.27M | 4.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $3.82B | 49.61 | -14.04% | ― | 48.29% | -1436.25% | |
65 Neutral | $8.53B | 7.95 | 23.93% | ― | 16.12% | 10.99% | |
58 Neutral | $12.85B | 6.69 | 7.50% | ― | 12.96% | -23.25% | |
55 Neutral | $2.93B | ― | -38.50% | ― | 49.46% | 66.89% | |
51 Neutral | $7.44B | -0.20 | -46.00% | 2.27% | 22.80% | -2.27% | |
50 Neutral | $1.32B | ― | -12.59% | ― | -4.87% | 66.16% | |
44 Neutral | $24.18M | ― | 94.19% | ― | -24.84% | 43.21% |
Marpai, Inc. announced on August 4, 2025, that it has entered into a Securities Purchase Agreement with investor parties, dated July 29, 2025. This agreement marks a significant step for Marpai, potentially impacting its financial operations and market positioning.
On July 17, 2025, Marpai Health Inc. entered into a Securities Purchase Agreement with investor parties, as documented in a recent filing. This agreement marks a significant step in Marpai’s financial strategy, potentially impacting its market position and stakeholder interests.